Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype

BACKGROUND: Metaplastic breast cancer (MBC) is a rare and aggressive subtype of the breast. To understand the characteristics and prognosis of single hormone receptor-positive (HR+) MBC (estrogen receptor-positive [ER+]/progesterone receptor-negative [PR-] and ER-/PR+), we compared these tumors to d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Mao, Jinqian, Hu, Jin, Zhang, Yanting, Shen, Jian, Dong, Fang, Zhang, Ximeng, Ming, Jie, Huang, Tao, Run, Xiaoqin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105402/
https://ncbi.nlm.nih.gov/pubmed/33972826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.628939
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars